Read more about the article Albert Labs Chief Medical Officer on the MHRA’s new guidance on use of Real-world Data and Real-World Evidence in Clinical Trials

Albert Labs Chief Medical Officer on the MHRA’s new guidance on use of Real-world Data and Real-World Evidence in Clinical Trials

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Chief Medical Officer on the MHRA’s new guidance on use of Real-world Data and Real-World Evidence in Clinical Trials
Read more about the article Press Release: MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway

Press Release: MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingPress Release: MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway